Source: International Congress 2019 – Involvement of the environment and inflammation in pulmonary remodelling
Disease area: Interstitial lung diseases, Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Y. Nakahara (Nagoya, Japan), N. Hashimoto (Nagoya, Japan), K. Sakamoto (Nagoya, Japan), A. Ando (Nagoya, Japan), M. Inoue (Nagoya, Japan), A. Suzuki (Nagoya, Japan), A. Enomoto (Nagoya, Japan), Y. Hasegawa (Nagoya, Japan). The new-defined mesenchymal stromal/stem cell marker has a protective role in the development of acute lung injury.. 2449

Member's Comments

No comment yet.

Related content which might interest you: Characterization of human mesenchymal stem cells phenotype and secretome in a in vitro model of acute lung injury inflammation Source: Annual Congress 2011 - Lung cell injury and repair Year: 2011 Protective roles of paracrine factors of bone marrow mesenchymal stem cells in bleomycin induced lung epithelial cell injury in vitro and pulmonary fibrosis in vivo Source: Annual Congress 2010 - Experimental approaches in pulmonary fibrosis Year: 2010 Human mesenchymal stem cell exosomes attenuate inflammation of lung epithelial cells through miR-223 in acute lung injury Source: International Congress 2019 – Cellular responses and cell therapy in lung injury and repair Year: 2019 The role of resident lung mesenchymal stromal cells in normal and aberrant lung development Source: Virtual Congress 2020 – Cellular involvement in lung injury Year: 2020 Mesenchymal stromal (stem) cell therapy modulates miR-193b-5p expression to attenuate sepsis-induced acute lung injury Source: Eur Respir J, 59 (1) 2004216; 10.1183/13993003.04216-2020 Year: 2022 The role of epithelial to mesenchymal transition (EMT) in airway remodelling after human lung transplantation Source: Annual Congress 2008 - Vascular and interstitial remodelling in chronic lung disease: therapeutic interventions on the horizon Year: 2008 The therapeutic potential of the mesenchymal stem cell secretome in a mouse model of chronic inflammatory lung disease Source: International Congress 2019 – Cellular responses and cell therapy in lung injury and repair Year: 2019 Immunotherapeutic strategy with mesenchymal stem cells modulating inflammation in an experimental model of COPD. Source: Virtual Congress 2020 – New insight into the immunology of asthma and COPD Year: 2020 Therapeutic potential of mesenchymal stem cells to attenuate immune cell tolerance in a late stage model of sepsis Source: Virtual Congress 2020 – Physiological and cellular mechanisms affecting pulmonary pathologies Year: 2020 Rescue of murine silica-induced lung injury and fibrosis by human embryonic stem cells Source: Eur Respir J 2012; 39: 446-457 Year: 2012 Mesenchymal stem cell therapy reduces inflammation and damage in a model of chronic lung disease Source: ERS Lung Science Conference 2017 Year: 2017 Minimally cultured bone marrow mesenchymal stem cells ameliorate fibrotic lung injury Source: Eur Respir J 2009; 34: 740 Year: 2009 NKG2D mediated cytotoxicity towards respiratory epithelial cells suggests a mechanism for lung injury following allogeneic stem cell transplantation Source: Annual Congress 2007 - Epithelial networks in the airways Year: 2007 The use of alveolar epithelial type I cell-selective markers to investigate lung injury and repair Source: Eur Respir J 2004; 24 : 664-673 Year: 2004 In search of ckit+ stem cells in lung tissue Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema Year: 2015 Modulating progenitor accumulation attenuates lung angiogenesis in a mouse model of asthma Source: Eur Respir J 2011; 38: 679-687 Year: 2011